KCNK2 Antikörper (AA 4-14)
Kurzübersicht für KCNK2 Antikörper (AA 4-14) (ABIN5540445)
Target
Alle KCNK2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 4-14
-
Sequenz
- SASRERPGYT A
-
Spezifität
- This antibody reacts with the 47 kDa TREK-1 in Jurkat cell extract.
-
Aufreinigung
- Protein G affinity
-
Immunogen
- A synthetic peptide derived from the amino sequence 4-14 of human TREK-1, conjugated with KLH
-
-
-
-
Applikationshinweise
- ELISA: The antibody (1:500,000 diluted) can detect the TREK-1 peptide coated on ELISA plate at 100 ng/well. Western blot: Dilute approx. 1:3,000 to detect the 47 kDa TREK-1 in Jurkat cell extract.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- 0.01M PBS, pH 7.4
-
Konservierungsmittel
- Azide free
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store lyophilized at 2-8°C for 6 month or at -20°C long term. After reconstitution store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C long term. Avoid repeated freezing and thawing. Shelf life: one year from despatch.
-
Haltbarkeit
- 12 months
-
-
- KCNK2 (Potassium Channel, Subfamily K, Member 2 (KCNK2))
-
Andere Bezeichnung
- kcnk2
-
Hintergrund
- TWIK-related potassium channel 1(TREK-1), also known as K2P2.1, is a two pore domain gated potassium channel that is involved with pain reception. TREK-1 is highly expressed in small sensory neurons and is extensively colocalized with TRPV1. TREK-1 is sensitive to noxious stimuli including extracellular pH , temperature, mechanical force, osmotic pressure and other stimuli. TREK-1 is one of the targets for pain mediator and anaesthesia drug.
Target
-